Press releases
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
- Haemonetics Corporation Completes Acquisition of Attune Medical
- Haemonetics Announces Definitive Agreement to Acquire Attune Medical
- Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
- Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
More ▼
Key statistics
On Friday, Haemonetics Corp (HAZ:FRA) closed at 75.50, 16.15% above the 52 week low of 65.00 set on Feb 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 77.00 |
---|---|
High | 77.00 |
Low | 75.50 |
Bid | -- |
Offer | -- |
Previous close | 78.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 50.79m |
Free float | 50.40m |
P/E (TTM) | 32.87 |
Market cap | 4.13bn USD |
EPS (TTM) | 2.47 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 20:49 BST.
More ▼